Needham & Company Starts Teleflex (TFX) at Buy

Needham & Company initiates coverage on Teleflex (NYSE: TFX) with a Buy rating and a price target of $221.00.

Analyst Mike Matson commented, "We are initiating coverage of TFX with a Buy rating. As a medical supplies company, TFX's products are less vulnerable to pricing pressure and offer economic benefits to hospitals. We expect new products to drive faster revenue growth while TFX continues to deliver significant margin improvement. And despite paying a high multiple for VASC, we think that the deal will prove highly beneficial by increasing TFX's revenue growth, margins, and EPS."

For an analyst ratings summary and ratings history on Teleflex click here. For more ratings news on Teleflex click here.

Shares of Teleflex closed at $194.35 yesterday.

You May Also Be Interested In

• Berenberg Starts Natwest Group PLC (NWG:LN) (NWG) at Buy
• Axis Capital Limited Upgrades Infosys Ltd. (INFO:IN) (INFY) to Buy (1)
• Axis Capital Limited Downgrades Wipro Ltd. (WPRO:IN) (WIT) to Reduce (3)